ClinVar Miner

Submissions for variant NM_002230.4(JUP):c.998G>A (p.Arg333His)

gnomAD frequency: 0.00005  dbSNP: rs727503099
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000150850 SCV000198404 uncertain significance not specified 2013-04-21 criteria provided, single submitter clinical testing The Arg333His variant in JUP has not been reported in individuals with cardiomyo pathy or in large population studies. Computational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide st rong support for or against an impact to the protein. Additional studies are nee ded to fully assess the clinical significance of this variant.
Labcorp Genetics (formerly Invitae), Labcorp RCV001850054 SCV002128331 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2024-01-28 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 333 of the JUP protein (p.Arg333His). This variant is present in population databases (rs727503099, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with JUP-related conditions. ClinVar contains an entry for this variant (Variation ID: 163720). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002381468 SCV002689651 uncertain significance Cardiovascular phenotype 2024-12-07 criteria provided, single submitter clinical testing The c.998G>A (p.R333H) alteration is located in exon 6 (coding exon 5) of the JUP gene. This alteration results from a G to A substitution at nucleotide position 998, causing the arginine (R) at amino acid position 333 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Fulgent Genetics, Fulgent Genetics RCV001850054 SCV002816021 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2021-09-01 criteria provided, single submitter clinical testing
GeneDx RCV004783754 SCV005396517 uncertain significance not provided 2024-05-08 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.